Abstract

Saffold virus (SAFV) was identified as a human cardiovirus in 2007. Although several epidemiological studies have been reported, they have failed to provide a clear picture of the relationship between SAFV and human diseases. SAFV genotype 3 has been isolated from the cerebrospinal fluid specimen of patient with aseptic meningitis. This finding is of interest since Theiler’s murine encephalomyelitis virus (TMEV), which is the closely related virus, is known to cause a multiple sclerosis-like syndrome in mice. TMEV persistently infects in mouse macrophage cells in vivo and in vitro, and the viral persistence is essential in TMEV-induced demyelinating disease. The precise mechanism(s) of SAFV infection still remain unclear. In order to clarify the SAFV pathogenicity, in the present study, we studied the possibilities of the in vitro persistent infection of SAFV. The two distinct phenotypes of HeLa cells, HeLa-N and HeLa-R, were identified. In these cells, the type of SAFV-3 infection was clearly different. HeLa-N cells were lyticly infected with SAFV-3 and the host suitable for the efficient growth. On the other hand, HeLa-R cells were persistently infected with SAFV-3. In addition, the SAFV persistence in HeLa-R cells is independent of type I IFN response of host cells although the TMEV persistence in mouse macrophage cells depends on the response. Furthermore, it was suggested that SAFV persistence may be influenced by the expression of receptor(s) for SAFV infection on the host cells. The present findings on SAFV persistence will provide the important information to encourage the research of SAFV pathogenicity.

Highlights

  • Saffold virus (SAFV) was identified from an infant with a fever of unknown origin in 2007 [1]

  • We first investigated on the differences of the growth of Saffold Virus Type 3 (SAFV-3) in two HeLa cell lines, HeLa-N and HeLa-R, which are derived from different laboratories

  • The cytopathic effect (CPE) by SAFV-3 infection on HeLa-N cells cultured with fetal calf serum (FCS) are severer than that on HeLa-N cells pre-cultured with calf serum (CS) for 2 weeks

Read more

Summary

Introduction

Saffold virus (SAFV) was identified from an infant with a fever of unknown origin in 2007 [1]. SAFV was isolated from nasal and stool specimens from infants presenting with respiratory or gastrointestinal symptoms. Several epidemiological studies have been reported, they have failed to provide a clear picture of the relationship between SAFV and human diseases [7]. Animal experiments have been carried out and two different groups reported that SAFV is neurotropic in mice [9,10]. These findings are of interest since TMEV, which is the closely related virus, is known to cause a multiple sclerosis-like syndrome in mice. The precise mechanism(s) of SAFV infection still remain unclear

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call